Other OTC Pharmaceuticals (Pharmacies) - Burkina Faso

  • Burkina Faso
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$10.47m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.70%, resulting in a market volume of US$10.84m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.44 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Burkina Faso is experiencing significant growth and development.

Customer preferences:
Customers in Burkina Faso have shown a strong preference for over-the-counter (OTC) pharmaceutical products in recent years. This can be attributed to several factors, including the convenience and accessibility of these products, as well as the increasing awareness and importance of self-care among the population. Additionally, the relatively lower cost of OTC medications compared to prescription drugs makes them a more affordable option for many consumers.

Trends in the market:
One of the key trends in the Other OTC Pharmaceuticals (Pharmacies) market in Burkina Faso is the growing demand for herbal and traditional medicines. Burkina Faso has a rich tradition of using herbal remedies for various health conditions, and this trend has gained momentum in recent years. Consumers are increasingly seeking natural alternatives to conventional OTC medications, driven by a desire for more holistic and sustainable approaches to healthcare. Another trend in the market is the increasing availability and variety of OTC pharmaceutical products. Pharmacies in Burkina Faso are expanding their product offerings, providing a wider range of OTC medications to meet the diverse needs of consumers. This includes not only traditional OTC drugs such as pain relievers and cough syrups, but also products for skin care, digestive health, and other specific health concerns.

Local special circumstances:
One of the key factors influencing the development of the Other OTC Pharmaceuticals (Pharmacies) market in Burkina Faso is the country's healthcare infrastructure. Burkina Faso has a relatively low number of healthcare facilities, particularly in rural areas. As a result, pharmacies play a crucial role in providing accessible healthcare services to the population. This has led to a growing demand for OTC medications, as pharmacies serve as the primary point of contact for many consumers seeking healthcare advice and treatment.

Underlying macroeconomic factors:
Burkina Faso is experiencing steady economic growth, which has positively impacted the Other OTC Pharmaceuticals (Pharmacies) market. As the country's economy expands, consumers have more disposable income to spend on healthcare products, including OTC medications. This has contributed to the increasing demand for OTC pharmaceuticals in the country. In addition, the government of Burkina Faso has implemented policies to improve access to healthcare services, including the availability of OTC medications. This includes initiatives to increase the number of pharmacies and improve their distribution networks, ensuring that OTC pharmaceuticals are readily accessible to all segments of the population. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Burkina Faso is witnessing significant growth and development. Customer preferences for OTC medications, the increasing availability of products, and the country's healthcare infrastructure are driving this growth. Additionally, underlying macroeconomic factors such as economic growth and government initiatives are further supporting the expansion of the market. Overall, the future looks promising for the Other OTC Pharmaceuticals (Pharmacies) market in Burkina Faso.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)